title: [Indication for the treatment of Helicobacter pylori infection].
abstract: Helicobacter pylori is a microorganism that is thought to play a role in the etiopathogenesis of peptic ulcer disease. Eradication of this microorganism is valuable clinical cure of infected patients. Efficacious regimens generally include an antisecretory agent combined with two antimicrobials. The main determinant of overall cost of treatment is the rate of eradication of the microorganism. Resistance can occur to the commonly used antibiotics but can usually be overcome with an altered regimen. It is important for care physicians to clearly understand indication and how to select appropriate therapy against Helicobacter pylori infection.
authors.affiliation: Gastroenterologické centrum--IV. interní klinika 1. LF UK a VFN, Praha. tsvest@vfn.cz
authors.forename: T
authors.initials: T
authors.lastname: Svestka
authors.forename: T
authors.initials: T
authors.lastname: Krechler
authors.forename: R
authors.initials: R
authors.lastname: Brůha
authors.forename: M
authors.initials: M
authors.lastname: Jablonská
mesh_terms: D004359:Drug Therapy, Combination; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000382:microbiology; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans